In 1975, Dr. Howard Lee established Lee Scientific, Inc, isolating gGT from bovine kidneys for the diagnostic market. For the next 10 years, he dedicated his life producing high quality bovine enzymes. In 1985, Dr. Lee passed away from cancer and the industry lost a great visionary. In 1986, his son, Burton Lee left his position at Dow Chemical at 28 years old to work at the family business as a Sales Manager to try and regain what was lost in Dr. Lee’s absence. In 1988, Burton was promoted to Executive Vice President introducing a new line of cardiac and tumor markers to the industry.

Burton purchased the family business in 2002 and renamed it Lee Biosolutions, Inc., reflecting the new business strategy of solving customer problems and introducing innovative solutions with high quality products. In 2012 Matt Lee came on board after a successful internship as Logistics Manager. In 2014, Matt Lee was promoted to Vice-President of Business Operations and then to President and COO in 2015 to handle the increase in day-to-day activities and assist Burton Lee, CEO in applying creative solutions to strategic challenges in order to maximize our growth potential.

August of 2015 Lee Biosolutions moved into a  41,000 ft² (12,496 m²) research and manufacturing facility with clean room for contract protein purification. ISO 13485:2008 was achieved in 2016 and Lee Biosolutions acquired Creative Laboratory Products in 2016, increasing its portfolio of manufactured products to include lipoproteins, cholesterol and triglycerides.